MLchartDataset catalogue

Tranexamic acid

Term · Oncology and biomedicine · MLC-T-ONC-017288

A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action.

Table 1. Record
IdentifierMLC-T-ONC-017288
FieldOncology and biomedicine
Synonymstranhexamic acid
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017288",
  "term": "Tranexamic acid",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action.",
  "synonyms": [
    "tranhexamic acid"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tranexamic-acid/"
}

Record 16,598 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.